Every year, World Prostate Cancer Day reminds us of the importance of continuing to advance in prevention, early diagnosis and medical innovation. As a urologist, I have spent many years witnessing how this disease has been transformed by technology, research and precision medicine.
Today, prostate cancer is no longer managed in the same way it was ten years ago. And, most likely, in another ten years, we will look back again and be amazed by how much further we have progressed.
This is precisely one of the most fascinating aspects of medicine: our constant responsibility to evolve in order to offer treatments that are increasingly precise, less invasive and have a lower impact on patients’ quality of life.
Yet there is one thing that remains just as important as ever: detecting prostate cancer at an early stage.
The Greatest Challenge in Prostate Cancer Remains Early Detection
One of the main challenges of this disease is that, in its early stages, it often causes no symptoms. Many patients come to see us feeling perfectly well and showing no obvious warning signs.
That is why I always emphasise the importance of discussing with a urologist when prostate assessment should begin, taking into account age, family history and each patient’s individual risk profile. Early detection remains one of our most valuable tools for identifying clinically significant tumours.
Detecting the disease while it is still localised can dramatically change the prognosis. When prostate cancer is diagnosed early, the chances of curative treatment are very high and, importantly, we are often able to offer far less aggressive therapeutic options.
Today, we have diagnostic tools that have significantly improved our ability to identify clinically relevant tumours, including:
- PSA testing,
- multiparametric MRI,
- MRI-targeted fusion prostate biopsy,
- biomarkers,
- and increasingly sophisticated diagnostic intelligence.
Thanks to these technologies, we are now able to diagnose more accurately, treat more effectively and avoid unnecessary procedures for many patients.
Technology Is Transforming Urology and Prostate Cancer Treatment
Technological innovation has revolutionised our specialty in a remarkably short period of time.
When I began my training, many surgical procedures were considerably more invasive, and recovery was often slower and more challenging. Today, robotic surgery, advanced imaging and minimally invasive techniques allow us to operate with a level of precision that would have seemed unimaginable just a few years ago.
Technology does not replace the physician. However, it enables us to make better-informed decisions and deliver treatments that are safer, more personalised and more effective.
In prostate cancer, this is particularly important because our goal is not simply to control the disease. We also strive to preserve urinary continence, sexual function and, ultimately, the patient’s quality of life.
This shift in focus represents one of the most significant advances in modern urology.
Personalised Medicine Will Shape the Future of Prostate Cancer Care
One of the most important developments in recent years is that we are moving away from the concept of “one treatment fits all”.
We now understand that every prostate cancer is different and that every patient requires an individualised strategy.
The combination of advanced diagnostics, genetics, robotic surgery, focal therapies and novel treatments enables us to tailor clinical decisions far more effectively to both the characteristics of the tumour and the needs of the patient.
And this evolution is only just beginning.
Artificial intelligence, precision medicine and the development of new diagnostic technologies are set to shape the future of urology in the years ahead. All indications suggest that we will be able to diagnose prostate cancer even earlier and offer treatments that are increasingly personalised and less invasive.
Prevention and Early Detection Remain Essential
On a day such as this, it is important to remember that technology alone is not enough if patients are not diagnosed in time.
Early detection and appropriate urological assessment remain fundamental to expanding treatment options, improving outcomes and preserving quality of life.
Encouraging open conversations about men’s health, overcoming the reluctance to seek specialist advice and understanding that early diagnosis saves lives continue to be among our greatest responsibilities as physicians.
Because the earlier we detect the disease, the greater the opportunity to treat it successfully while preserving the patient’s quality of life.
And that is where medicine truly makes a difference.
